Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDX versus atomoxetine time-to-response study in children and adolescents with ADHD after inadequate response to methylphenidate
2009-011745-94Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Lisdexamfetamine dimesylate with Atomoxetine hydrochloride (2 arms). Primary endpoint: Time to response. Started Jul 2009; status: completed.
02
Drugs
lisdexamfetamineatomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2009-011745-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011745-94.